What Is The Current and Historic Market Size Analysis Of The Drug Discovery Informatics Market?
The drug discovery informatics market has seen considerable growth due to a variety of factors.
• In recent times, the market size of drug discovery informatics has experienced a notable rise. It is projected to increase from $3.69 billion in 2024 to $4.09 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. The growth observed in the historic period can be credited to the advancements in genomics and proteomics, the rising complexity in drug targets, development in structural biology, increase in outsourcing, integration of pharmacogenomics, and strategies for drug repurposing.
What Is The Forecast For The Drug Discovery Informatics Market Size?
The Drug Discovery Informatics market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the drug discovery informatics market is predicted to experience a swift expansion. It is projected to reach a market size of $6.98 billion in 2029 with a compound annual growth rate (CAGR) of 14.3%.
The significant growth during the projection period can be credited to factors like precision medicine expansion, prediction of drug-drug interaction, analysis of patient-derived data, biosimilars development, and increase in the number of drug candidates. The period is also expected to witness major trends like the integration of ai and machine learning, the introduction of digital twins in drug development, the rise of collaboration platforms, use of blockchain for data security, advancements in imaging technologies, and the emergence of cloud-based informatics platforms.
What Are The Essential Drivers Behind The Growth Of The Drug Discovery Informatics Market?
Accelerating incidences of diverse chronic ailments are projected to drive the expansion of the drug discovery informatics market. Chronic illnesses are broadly characterized as conditions that last for a year or more, requiring ongoing medical care, restricting daily activities, or both. Drug discovery informatics infrastructure supports chronic disease management by enabling researchers to delve into more intricate and short-term molecular alterations that underlie disease advancement and drug reaction, leading to comprehensive models of the entire hierarchical system in states of health, disease, and treatment. For example, as per a report by the World Health Organization, a UN-established Switzerland-based institution accountable for global health, the projected deaths in 2022 due to non-communicable diseases (NCDs) are 41 million, signifying 74% of worldwide deaths. Every year, before reaching the age of 70, 17 million people succumb to an NCD, with 86% of these premature deaths occurring in low-and middle-income countries. Cardiovascular diseases cause the highest number of deaths (17.9 million), followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (2.0 million, including deaths from kidney diseases due to diabetes). Therefore, the increasing prevalence of assorted chronic diseases is the major push factor for the drug discovery informatics market's growth.
How Is The Global Drug Discovery Informatics Market Divided Into Key Segments?
The drug discovery informatics market covered in this report is segmented –
1) By Service: In-House, Outsourced
2) By Modality: Cloud-Based Systems, In-Campus
3) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies
Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling, Other In-House Services
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services, Other Outsourced Services
Pre-Book The Drug Discovery Informatics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Drug Discovery Informatics Market?
The rise in technological advancements has been identified as a significant trend prevalent in the drug discovery informatics market. Predominant players in the market are striving to develop state-of-the-art solutions to maintain and boost their market dominance. Take for example the US-based biotechnology company, Illumina Inc., which launched a new cloud-based software named Connected Insights in March 2023. This software allows tertiary analysis for clinical next-generation sequencing (NGS) data, aiming to simplify interpretations and report production from various assay types. This would allow labs to increase their use of NGS and diminish the waiting time for clinical reports through the integration of third-party knowledge bases. Soon to support a broad range of applications, including whole-genome sequencing (WGS) for rare diseases, the Illumina Connected Software is a comprehensive software ecosystem which standardizes analysis tools and interconnects data throughout the genomics workflow. Working in tandem with Illumina sequencers and the DRAGEN secondary analysis, the Illumina Connected Software provides a highly precise, adaptable analysis environment ready to be scaled according to each client's workflow needs.
Who Are the Key Players In The Drug Discovery Informatics Market?
Major companies operating in the drug discovery informatics market include:
• Accenture Plc.
• Certara Inc.
• Charles River Laboratories Inc.
• Infosys Ltd.
• Collaborative Drug Discovery Inc.
• Eurofins DiscoverX Products Inc.
• Jubilant Biosys Ltd.
• Selvita S.A.
• PerkinElmer Inc.
• International Business Machines Corporation
• Boehringer Ingelheim International GmbH
• Oracle Corporation
• Thermo Fisher Scientific Inc.
• Albany Molecular Research Inc.
• ChemAxon Ltd.
• Amazon Web Services Inc.
• Schrödinger LLC.
• Core Informatics LLC
• Informatics Matters Ltd.
• Tata Consultancy Services Limited
• Novo Informatics Pvt. Ltd.
• IO Informatics Inc.
• GVK Biosciences Private Limited
• Dassault Systèmes SE
• Recursion Pharmaceuticals Inc.
• Cyclica Inc.
• Valence Discovery Inc.
• Valo Health Inc.
• Cognizant Technology Solutions Corporation
• Wipro Limited
• Mindtree Limited
• Persistent Systems Limited
• Mphasis Limited
What Are The Regional Insights Into The Drug Discovery Informatics Market?
North America was the largest region in the drug discover informatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
